Yet, when we evaluated the expression of CPT2 protein in patients TMAs; however, due to the lack of a GBM-specific marker to co-stain with, it was not possible to conclude whether the observed CPT2 protein expression in the invasive margin is exclusively localised to the tumour cell population. Here, CPT2 is linked to neoplasm.